Novacyt Says Covid-19 Contract Dispute with UK Health Department Continues
16 9월 2021 - 5:48PM
Dow Jones News
By Sabela Ojea
Novacyt SA said Thursday that it continues to work with its
legal advisers to progress the U.K. Department of Health and Social
Care's dispute over a supply contract.
In April the clinical-diagnostics specialist, which is listed in
France and the U.K., said the parties haven't reached an agreement
to extend the contract for the supply of Covid-19 diagnostic kits
and other products.
The London-listed company also said that the accounting
treatment of the DHSC revenue and costs in the first half doesn't
change its legal position or rights in relation to the dispute.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
September 16, 2021 04:33 ET (08:33 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Novacyt (EU:ALNOV)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Novacyt (EU:ALNOV)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
